0

Global Hemophilia Drugs Market 2016-2020

  • Published: Oct 2016
  • Pages: 84
  • SKU: IRTNTR10470
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

This market research report examines the competitive landscape and includes some leading market players such as Baxalta, Bayer, CSL Behring, Novo Nordisk, and Pfizer. This study provides an in-depth analysis of the market by type of disease (hemophilia A, inhibitors, hemophilia B, and Von Willebrand disease), type of therapy (recombinant therapies and plasma-derived therapies), disease management (prophylaxis, on-demand therapy, and inhibitor therapy), and geography (Americas, APAC, and EMEA).

Increasing focus on prophylactic treatment is a key driver for the global hemophilia drugs market

Extensive research carried out by the analysts at Technavio has shown that the global hemophilia drugs market will witness steady growth and will post a moderate CAGR of more than 5% over the forecast period. With an increasing focus on prophylactic treatment, the market for hemophilia drugs is expected to have a positive outlook over the coming years. The prophylactic treatment approach prevents spontaneous bleeding episodes, significantly improves the quality of life in terms of physical activities, and maintains the level of clotting factors above a baseline.

According to the studies conducted by the US National Library of Medicine determined that the savings on prophylactic treatment be approximately USD 8,312 to USD 17,675 per bleeding episode in a person. Moreover, this line of treatment reduces joint damage and suffering from pain. Several such long-acting therapeutics are under development and expected to be launched over the next four years. The shift in preference for prophylactic treatment due to its advantages will drive this market’s growth.

Hemophilia drugs market based on geography

According to the hemophilia market overview, the Americas led the global hemophilia drugs market in 2015 and is expected to continue its dominance until the end of 2020. The Americas have the highest revenue share in the global market with the US contributing to the majority of this revenue. Several countries in the region have introduced health care reforms which are having a positive impact on market growth. Moreover, healthcare reforms in the US have also helped reduce the cost of pharmaceutical drugs, increased access to healthcare, and improved the overall quality of healthcare. These healthcare reforms are likely to have a positive impact on health care insurance and also reduce hospital stay and overall medical expenses, which will boost this market’s growth in the region.

Hemophilia drugs market: Competitive landscape and key vendors

The global hemophilia drugs market highly consolidated with key players including Baxalta, Bayer, CSL Behring, Novo Nordisk, Biogen, and Pfizer, which together account for the majority of market shares. The vendors are focusing on opportunities in emerging markets such as China and India to increase their market share.

 Some hemophilia drug companies are

  • Baxalta
  • Bayer
  • CSL Behring
  • Novo Nordisk
  • Pfizer

Hemophilia drugs market segmentation by type of disease 

  • Hemophilia A
  • Inhibitors
  • Hemophilia B
  • Von Willebrand disease

During 2015, the Hemophilia A segment dominated the market and is expected to lead the market during the forecast period. Hemophilia A is more prevalent than hemophilia B and Von Willebrand disease. The development of novel drugs with prolonged action and the increased adoption of prophylactic treatment among individuals will boost this market segment’s growth in the future. The on-demand hemophilia A prophylactics are expected to witness greater acceptance in the emerging countries.

Hemophilia drugs market by type of therapy

  • Recombinant therapies
  • Plasma-derived therapies

According to the industry research analysts, the recombinant therapies segment accounted for most of the market revenue shares and will continue to lead the market over the coming years. The growth of this segment is attributed to the increasing demand for prophylaxis therapies in developed countries and shift in preference from plasma-derived therapies to recombinant products in the emerging economies. Moreover, the entry of long-acting recombinant products such as ALPROLIX by Biogen, Advate by Baxter, among others will contribute to this segment’s growth over the coming years.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global hemophilia drugs market?
  • What are the key market trends impacting the growth of the global hemophilia drugs market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global hemophilia drugs market?
  • What are the market opportunities and threats faced by the vendors in the global hemophilia drugs market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global hemophilia drugs market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

 

 

Table of Content

 PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Pipeline portfolio

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by type of disease

  • Global hemophilia A drugs market
  • Global hemophilia inhibitors treatment market
  • Global hemophilia B drugs market
  • Global von Willebrand disease treatment market

PART 08: Market segmentation by type of therapy

  • Recombinant therapies
  • Plasma-derived therapies

PART 09: Market segmentation by type of disease management

  • Prophylaxis
  • On-demand therapy
  • Inhibitor therapy

PART 10: Geographical segmentation

  • Hemophilia drugs market in Americas
  • Hemophilia drugs market in EMEA
  • Hemophilia drugs market in APAC

PART 11: Market drivers

  • Focus on prophylactic treatment
  • Drugs with prolonged action
  • Improved diagnostic procedures

PART 12: Impact of drivers

PART 13: Market challenges

  • Low diagnosis rate
  • High entry barriers
  • Cost-intensive complex treatment

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Increase in technological innovations
  • Development of gene therapy products
  • Centralized buyers should pave the way to increased penetration

PART 16: Vendor landscape

  • Competitive scenario
  • Other prominent vendors

PART 17: Key vendor analysis

  • Baxalta
  • Bayer
  • CSL Behring
  • Novo Nordisk
  • Pfizer

PART 18: Appendix

  • List of abbreviations

PART 19: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>